Invention Grant
- Patent Title: Substituted phenyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
-
Application No.: US16631191Application Date: 2018-07-30
-
Publication No.: US11208407B2Publication Date: 2021-12-28
- Inventor: Hua Zhou , Abdelghani Achab , Xavier Fradera , Yongxin Han , Derun Li , Meredeth A. McGowan , Nunzio Sciammetta , David L. Sloman , Wensheng Yu
- Applicant: Merck Sharp & Dohme Corp.
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Yong Zhao; Catherine D. Fitch
- International Application: PCT/US2018/044273 WO 20180730
- International Announcement: WO2019/027855 WO 20190207
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D235/14

Abstract:
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: (I) Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
Public/Granted literature
- US20200216443A1 NOVEL SUBSTITUTED PHENYL COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS Public/Granted day:2020-07-09
Information query